Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer Stage ⅢA (Resectable)”

3 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 3 of 3 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04699721
What this trial is testing

Clinical Study of Neoadjuvant Chemotherapy and Immunotherapy Combined With Probiotics in Patients With Resectable NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage ⅢANon-small Cell Lung Cancer Stage IIIB
Xiangya Hospital of Central South University 60
Not applicableLooking for participantsNCT06250829
What this trial is testing

Model to Predict pCR and IrAEs in Early Stage Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage IB (Resectable)Non-small Cell Lung Cancer Stage II (Resectable)Non-small Cell Lung Cancer Stage ⅢA (Resectable)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 60
Testing effectiveness (Phase 2)UnknownNCT05170581
What this trial is testing

Clinical Study of Sintilimab Combined With Chemotherapy in Neoadjuvant Treatment of Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
The Second Affiliated Hospital of Shandong First Medical University 30